National and Kapodistrian University of Athens
Χορήγηση αργινίνης σε πρόωρα νεογνά και μέτρηση της καλπροτεκτίνης των κοπράνων ως δείκτη φλεγμονής του εντέρου
Abstract
dc:descriptionObjective: To determine the potential effect of oral L-arginine supplementation on intestinal inflammation in very low birth weight (VLBW) preterm infants, as estimated by faecal calprotectin levels and the incidence and severity of NEC. Study design: The study enrolled 83 VLBW neonates with birth weight ≤ 1500 g and gestational age ≤ 34 weeks. In this double blind study 40 neonates received daily oral L-arginine supplementation of 1.5mmol/Kg/day between the 3rd and 28th day of life and 43 neonates received placebo. Stool samples were collected on days 3, 14 and 28 and calprotectin was measured by ELISA. Diagnosis and classification of NEC were done according to modified Bells’ criteria. The Pearson test was used for categorical variables, the t-test was used for normal continuous variables and the nonparametric Mann-Whitney test for non-normal variables. Results: Calprotectin values significantly decreased over time in both groups (p=0.032). No difference in faecal calprotectin values was recorded between neonates receiving arginine supplementation and neonates receiving placebo at days 3, 14 and 28. . No adverse effects were observed in neonates receiving arginine supplementation. No significant differences in calprotectin values between neonates who developed NEC or not were observed. The incidence of NEC stage III was significantly lower in the arginine supplemented group (2.5% vs 18.6%, p=0.030). The mortality of NEC is lower in the group receiving arginine supplementation (0% vs 9.3%, p=0.045). No breast milk fed neonate developed NEC. Conclusions: Faecal calprotectin values decrease with increasing postnatal age in VLBW infants but this is not related to arginine supplementation. Enteral L-arginine supplementation can be safely administered in the dose used in VLBW neonates. Enteral L-arginine supplementation seems to reduce the severity and mortality of NEC. Larger studies are required to assess the efficiency of L-arginine supplementation in the prevention of NEC. Breast milk appears to protect from NEC. Key words: Necrotizing enterocolitis (NEC), Nitric Oxide (NO), faecal calprotectin, L-arginine, Enzyme-linked immunosorbent assay (ELISA).
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Πολυκάρπου, Έλενα
- Polycarpou, Elena
Subjects
dc:subject × 15- Νεκρωτική εντεροκολίτιδα
- Μονοξείδιο του αζώτου
- Καλπροτεκτίνη κοπράνων
- L - Αργινίνη
- Πρόωρα νεογνά
- Necrotizing enterocolitis
- Nitric oxide (NO)
- Faecal calprotectin
- L-arginine
- Preterm neonates
- Enzyme-linked immunosorbent assay (ELISA)
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29970